Neurofibromatosis in children our experience

被引:5
作者
López-Pisón, J [1 ]
Cuadrado-Martín, M [1 ]
Boldova-Aguar, MC [1 ]
Muñoz-Mellado, A [1 ]
de Diago, RC [1 ]
Peña-Segura, JL [1 ]
机构
[1] Univ Zaragoza, Hosp Infant Miguel Servet, Secc Neuropediat, E-50009 Zaragoza, Spain
关键词
brain areas with hypersignals; Cafe au lait marks; childhood; magnetic resonance; neurofibromatosis type 1; neuropaediatric case mix; optic glioma;
D O I
10.33588/rn.3709.2003268
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder with a high index of spontaneous mutations and extremely varied and unpredictable clinical manifestations. It is diagnosed by the existence of certain clinical criteria which cannot appear until adulthood. Patients and methods. The clinical histories of the confirmed or possible cases of neurofibromatosis (NF) in the neuropaediatric databases at the Hospital Miguel Servet in Zaragoza and at the Hospital General in Guadalajara were analysed retrospectively. Results. Cases were distributed in 46 NFI, six compatible with NFI, 11 with just marks, five with marks and a family history of marks, and two cases of segmentary NF. Among the confirmed cases of NF1, the following alterations were found.- optic glioma (OG) in eight, and one of them developed a glioblastoma multiforme, multiple radicular neurofibromas in one, mental retardation in one and learning disorders in 13 of the 29 school-aged children, afebrile seizures in three, precocious puberty in two and scoliosis in nine. Brain areas with hypersignals were found in 71% of the cases submitted to magnetic resonance imaging (MRI) (20 out of 28), including seven of the eight patients suffering from OG. Discussion. Our case mix, like all the others, exemplifies the clinical heterogeneity and unpredictable progression of children with NFI or who are suspected of suffering from it. We followed the most widely used method of clinical and ophthalmological control, and complementary examinations were performed according to the clinical features. If neuroimaging is used, it must be MRI.
引用
收藏
页码:820 / 825
页数:6
相关论文
共 41 条
[1]   Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2 [J].
Abaza, MM ;
Makariou, E ;
Armstrong, M ;
Lalwani, AK .
LARYNGOSCOPE, 1996, 106 (06) :694-699
[2]   Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1 [J].
Cnossen, MH ;
Stam, EN ;
Cooiman, LCMG ;
Simonsz, HJ ;
Stroink, H ;
Oranje, AP ;
Halley, DJJ ;
deGoedeBolder, A ;
Niermeijer, MF ;
KeizerSchrama, SMPFD .
PEDIATRICS, 1997, 100 (04) :667-670
[3]   MRI diagnosis of NF-1 in children without cafe-au-lait skin lesions [J].
Curless, RG ;
Siatkowski, M ;
Glaser, JS ;
Shatz, NJ .
PEDIATRIC NEUROLOGY, 1998, 18 (03) :269-271
[4]   Use of the National Institutes of Health Criteria for diagnosis of neurofibromatosis 1 in children [J].
DeBella, K ;
Szudek, J ;
Friedman, JM .
PEDIATRICS, 2000, 105 (03) :608-614
[5]   Use of "unidentified bright objects" on MRI for diagnosis of neurofibromatosis 1 in children [J].
DeBella, K ;
Poskitt, K ;
Szudek, J ;
Friedman, JM .
NEUROLOGY, 2000, 54 (08) :1646-1650
[6]   NEUROFIBROMATOSIS TYPE-1 - MAGNETIC-RESONANCE-IMAGING FINDINGS [J].
DIMARIO, FJ ;
RAMSBY, G ;
GREENSTEIN, R ;
LANGSHUR, S ;
DUNHAM, B .
JOURNAL OF CHILD NEUROLOGY, 1993, 8 (01) :32-39
[7]   An association between optic glioma and other tumours of the central nervous system in neurofibromatosis type 1 [J].
Friedman, JM ;
Birch, P .
NEUROPEDIATRICS, 1997, 28 (02) :131-132
[8]   Neurofibromatosis 1: Clinical manifestations and diagnostic criteria [J].
Friedman, JM .
JOURNAL OF CHILD NEUROLOGY, 2002, 17 (08) :548-554
[9]   Neurofibromatosis bright objects in children with neurofibromatosis type 1: A proliferative potential? [J].
Griffiths, PD ;
Blaser, S ;
Mukonoweshuro, W ;
Armstrong, D ;
Milo-Mason, G ;
Cheung, S .
PEDIATRICS, 1999, 104 (04) :e49
[10]   Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1) [J].
Guillamo, JS ;
Créange, A ;
Kalifa, C ;
Grill, J ;
Rodriguez, D ;
Doz, F ;
Barbarot, S ;
Zerah, M ;
Sanson, M ;
Bastuji-Garin, S ;
Wolkenstein, P .
BRAIN, 2003, 126 :152-160